TG THERAPEUTICS, INC. Loans Payable
TG THERAPEUTICS, INC. (TGTX) had Loans Payable of $102.54 million as of 2024-06-30, per its 10-Q filed 2024-08-09.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable
us-gaap:LoansPayable · last filed 2024-08-09
- 2024-06-30: Loans Payable $102.54M.
- 2024-03-31: Loans Payable $101.33M.
- 2023-12-31: Loans Payable $100.12M.
- 2022-12-31: Loans Payable $71.14M.
| Period end | Loans Payable |
|---|---|
| 2024-06-30 | $102.54M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $101.33M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $100.12M 10-Q · filed 2024-08-09 |
| 2022-12-31 | $71.14M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |